Patents by Inventor Robert J. Lechleider

Robert J. Lechleider has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATIONS OF IMMUNOTHERAPIES AND USES THEREOF
    Publication number: 20230181732
    Abstract: Provided herein are uses of antibodies that bind to CD163 expressed on a human myeloid cell in combination with checkpoint inhibitors. Among other things, these CD163 antibodies can be used with checkpoint inhibitors in methods of treatment of humans, such as methods of treating a cancer or methods of relieving T cell suppression.
    Type: Application
    Filed: September 2, 2022
    Publication date: June 15, 2023
    Inventors: Siddarth Chandrasekaran, Tyrel T. Smith, Kamal D. Puri, Randi M. Simmons, Peter Probst, Robert J. Lechleider
  • Novel human septin and uses therefor
    Publication number: 20030124571
    Abstract: The invention provides a newly identified and isolated nucleotide sequence encoding a polypeptide referred to in the present application as ARTS, for Apoptosis Related protein in the TGF-&bgr; Signaling pathway.
    Type: Application
    Filed: July 29, 2002
    Publication date: July 3, 2003
    Applicant: The Government of the United States of America
    Inventors: Sarit Larisch, Seong-Jin Kim, Robert J. Lechleider, Anita B. Roberts, Youngsuk Yi